CAR-T Cell Therapy - Global and China Top Players Market Share and Ranking 2023
According to Latest Research, the global market for CAR-T Cell Therapy should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China CAR-T Cell Therapy market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States CAR-T Cell Therapy market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Non-hodgkin Lymphoma grew percent to account for percent of the total market sales, and Multiple Myeloma grew percent.
This report studies and analyses global CAR-T Cell Therapy status and future trends, helps the client to determine the CAR-T Cell Therapy market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for CAR-T Cell Therapy, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global CAR-T Cell Therapy market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global CAR-T Cell Therapy sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China CAR-T Cell Therapy sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global CAR-T Cell Therapy key consuming regions, consumption quantity, consumption value and demand structure
(5) Global CAR-T Cell Therapy key producing regions, capacity, production, and year over year growth
(6) CAR-T Cell Therapy industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Bristol Myers Squibb
Gilead Sciences
Novartis
Autolus
Janssen
JW Therapeutics
Beijing Immunochina Medical Science & Technology
Bioray Laboratories
Market segment by Type, covers
CD19
BCMA
CD19/CD22
Other
Market segment by Application, can be divided into
Non-hodgkin Lymphoma
Multiple Myeloma
Acute Lymphoblastic Leukemia
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe CAR-T Cell Therapy product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global CAR-T Cell Therapy market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China CAR-T Cell Therapy market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of CAR-T Cell Therapy, percent & CAGR, 2018-2029
Chapter 5: CAR-T Cell Therapy industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 CAR-T Cell Therapy Definition
1.2 Global CAR-T Cell Therapy Market Size and Forecast
1.2.1 By Consumption Value, Global CAR-T Cell Therapy Market Size，2018-2029
1.2.2 By Sales Quantity, Global CAR-T Cell Therapy Market Size，2018-2029
1.2.3 Global CAR-T Cell Therapy Average Selling Price (ASP)，2018-2029
1.3 China CAR-T Cell Therapy Market Size and Forecast
1.3.1 By Consumption Value, China CAR-T Cell Therapy Market Size，2018-2029
1.3.2 By Sales Quantity, China CAR-T Cell Therapy Market Size，2018-2029
1.3.3 China CAR-T Cell Therapy Average Selling Price (ASP)， 2018-2029
1.4 Share of China CAR-T Cell Therapy Market with Respect to the Global Market
1.4.1 By Consumption Value, China CAR-T Cell Therapy Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China CAR-T Cell Therapy Market Share in Global, 2018-2029
1.4.3 CAR-T Cell Therapy Market Size: China VS Global, 2018-2029
1.5 CAR-T Cell Therapy Market Dynamics
1.5.1 CAR-T Cell Therapy Market Drivers
1.5.2 CAR-T Cell Therapy Market Restraints
1.5.3 CAR-T Cell Therapy Industry Trends
1.5.4 CAR-T Cell Therapy Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of CAR-T Cell Therapy, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of CAR-T Cell Therapy, Global Market Share by Company, 2018-2023
2.3 CAR-T Cell Therapy Average Selling Price (ASP) by Company, 2018-2023
2.4 Global CAR-T Cell Therapy Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global CAR-T Cell Therapy Concentration Ratio
2.6 Global CAR-T Cell Therapy Mergers & Acquisitions, Expansion Plans
2.7 Global CAR-T Cell Therapy Manufacturers Product Type
2.8 Head Office and CAR-T Cell Therapy Production Site of Key Manufacturer
2.9 CAR-T Cell Therapy Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of CAR-T Cell Therapy, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of CAR-T Cell Therapy, China Market Share by Company, 2018-2023
3.3 China CAR-T Cell Therapy Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global CAR-T Cell Therapy Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global CAR-T Cell Therapy Capacity by Region
4.3 Global CAR-T Cell Therapy Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global CAR-T Cell Therapy Production by Region, 2018-2029
4.5 Global CAR-T Cell Therapy Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 CAR-T Cell Therapy Industry Chain
5.2 CAR-T Cell Therapy Upstream Analysis
5.2.1 CAR-T Cell Therapy Core Raw Materials
5.2.2 Main Manufacturers of CAR-T Cell Therapy Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 CAR-T Cell Therapy Production Mode
5.6 CAR-T Cell Therapy Procurement Model
5.7 CAR-T Cell Therapy Industry Sales Model and Sales Channels
5.7.1 CAR-T Cell Therapy Sales Model
5.7.2 CAR-T Cell Therapy Typical Distributors
6 Sights by Type
6.1 CAR-T Cell Therapy Classification
6.1.1 CD19
6.1.2 BCMA
6.1.3 CD19/CD22
6.1.4 Other
6.2 By Type, Global CAR-T Cell Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global CAR-T Cell Therapy Consumption Value, 2018-2029
6.4 By Type, Global CAR-T Cell Therapy Sales Quantity, 2018-2029
6.5 By Type, Global CAR-T Cell Therapy Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 CAR-T Cell Therapy Segment by Application
7.1.1 Non-hodgkin Lymphoma
7.1.2 Multiple Myeloma
7.1.3 Acute Lymphoblastic Leukemia
7.1.4 Other
7.2 By Application, Global CAR-T Cell Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global CAR-T Cell Therapy Consumption Value, 2018-2029
7.4 By Application, Global CAR-T Cell Therapy Sales Quantity, 2018-2029
7.5 By Application, Global CAR-T Cell Therapy Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global CAR-T Cell Therapy Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global CAR-T Cell Therapy Consumption Value, 2018-2029
8.3 By Region, Global CAR-T Cell Therapy Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America CAR-T Cell Therapy & Forecasts, 2018-2029
8.4.2 By Country, North America CAR-T Cell Therapy Market Size Market Share
8.5 Europe
8.5.1 Europe CAR-T Cell Therapy Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe CAR-T Cell Therapy Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific CAR-T Cell Therapy Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific CAR-T Cell Therapy Market Size Market Share
8.7 South America
8.7.1 South America CAR-T Cell Therapy Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America CAR-T Cell Therapy Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global CAR-T Cell Therapy Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global CAR-T Cell Therapy Consumption Value, 2018-2029
9.3 By Country, Global CAR-T Cell Therapy Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. CAR-T Cell Therapy Market Size, 2018-2029
9.4.2 By Type, U.S. CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe CAR-T Cell Therapy Market Size, 2018-2029
9.5.2 By Type, Europe CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China CAR-T Cell Therapy Market Size, 2018-2029
9.6.2 By Type, China CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan CAR-T Cell Therapy Market Size, 2018-2029
9.7.2 By Type, Japan CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea CAR-T Cell Therapy Market Size, 2018-2029
9.8.2 By Type, South Korea CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia CAR-T Cell Therapy Market Size, 2018-2029
9.9.2 By Type, Southeast Asia CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India CAR-T Cell Therapy Market Size, 2018-2029
9.10.2 By Type, India CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa CAR-T Cell Therapy Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Bristol Myers Squibb
10.1.1 Bristol Myers Squibb Company Information, Head Office, Market Area, and Industry Position
10.1.2 Bristol Myers Squibb CAR-T Cell Therapy Models, Specifications, and Application
10.1.3 Bristol Myers Squibb CAR-T Cell Therapy Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Bristol Myers Squibb Company Profile and Main Business
10.1.5 Bristol Myers Squibb Recent Developments
10.2 Gilead Sciences
10.2.1 Gilead Sciences Company Information, Head Office, Market Area, and Industry Position
10.2.2 Gilead Sciences CAR-T Cell Therapy Models, Specifications, and Application
10.2.3 Gilead Sciences CAR-T Cell Therapy Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Gilead Sciences Company Profile and Main Business
10.2.5 Gilead Sciences Recent Developments
10.3 Novartis
10.3.1 Novartis Company Information, Head Office, Market Area, and Industry Position
10.3.2 Novartis CAR-T Cell Therapy Models, Specifications, and Application
10.3.3 Novartis CAR-T Cell Therapy Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Novartis Company Profile and Main Business
10.3.5 Novartis Recent Developments
10.4 Autolus
10.4.1 Autolus Company Information, Head Office, Market Area, and Industry Position
10.4.2 Autolus CAR-T Cell Therapy Models, Specifications, and Application
10.4.3 Autolus CAR-T Cell Therapy Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Autolus Company Profile and Main Business
10.4.5 Autolus Recent Developments
10.5 Janssen
10.5.1 Janssen Company Information, Head Office, Market Area, and Industry Position
10.5.2 Janssen CAR-T Cell Therapy Models, Specifications, and Application
10.5.3 Janssen CAR-T Cell Therapy Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Janssen Company Profile and Main Business
10.5.5 Janssen Recent Developments
10.6 JW Therapeutics
10.6.1 JW Therapeutics Company Information, Head Office, Market Area, and Industry Position
10.6.2 JW Therapeutics CAR-T Cell Therapy Models, Specifications, and Application
10.6.3 JW Therapeutics CAR-T Cell Therapy Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 JW Therapeutics Company Profile and Main Business
10.6.5 JW Therapeutics Recent Developments
10.7 Beijing Immunochina Medical Science & Technology
10.7.1 Beijing Immunochina Medical Science & Technology Company Information, Head Office, Market Area, and Industry Position
10.7.2 Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Models, Specifications, and Application
10.7.3 Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Beijing Immunochina Medical Science & Technology Company Profile and Main Business
10.7.5 Beijing Immunochina Medical Science & Technology Recent Developments
10.8 Bioray Laboratories
10.8.1 Bioray Laboratories Company Information, Head Office, Market Area, and Industry Position
10.8.2 Bioray Laboratories CAR-T Cell Therapy Models, Specifications, and Application
10.8.3 Bioray Laboratories CAR-T Cell Therapy Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Bioray Laboratories Company Profile and Main Business
10.8.5 Bioray Laboratories Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. CAR-T Cell Therapy Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. CAR-T Cell Therapy Market Restraints
Table 3. CAR-T Cell Therapy Market Trends
Table 4. CAR-T Cell Therapy Industry Policy
Table 5. Global CAR-T Cell Therapy Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global CAR-T Cell Therapy Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global CAR-T Cell Therapy Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global CAR-T Cell Therapy Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global CAR-T Cell Therapy Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global CAR-T Cell Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global CAR-T Cell Therapy Mergers & Acquisitions, Expansion Plans
Table 12. Global CAR-T Cell Therapy Manufacturers Product Type
Table 13. Head Office and CAR-T Cell Therapy Production Site of Key Manufacturer
Table 14. CAR-T Cell Therapy Capacity of Major Manufacturers and Future Plan
Table 15. China CAR-T Cell Therapy Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China CAR-T Cell Therapy Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China CAR-T Cell Therapy Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global CAR-T Cell Therapy Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global CAR-T Cell Therapy Production by Region, 2018-2023, (K Units)
Table 20. Global CAR-T Cell Therapy Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of CAR-T Cell Therapy Upstream (Raw Materials)
Table 22. Global CAR-T Cell Therapy Typical Customers
Table 23. CAR-T Cell Therapy Typical Distributors
Table 24. By Type, Global CAR-T Cell Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global CAR-T Cell Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global CAR-T Cell Therapy Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global CAR-T Cell Therapy Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global CAR-T Cell Therapy Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global CAR-T Cell Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global CAR-T Cell Therapy Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global CAR-T Cell Therapy Consumption Value Market Share, 2018-2029
Table 32. By Country, Global CAR-T Cell Therapy Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global CAR-T Cell Therapy Sales Quantity Market Share, 2018-2029
Table 34. Bristol Myers Squibb Company Information, Head Office, Market Area, and Industry Position
Table 35. Bristol Myers Squibb CAR-T Cell Therapy Models, Specifications, and Application
Table 36. Bristol Myers Squibb CAR-T Cell Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Bristol Myers Squibb Company Profile and Main Business
Table 38. Bristol Myers Squibb Recent Developments
Table 39. Gilead Sciences Company Information, Head Office, Market Area, and Industry Position
Table 40. Gilead Sciences CAR-T Cell Therapy Models, Specifications, and Application
Table 41. Gilead Sciences CAR-T Cell Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Gilead Sciences Company Profile and Main Business
Table 43. Gilead Sciences Recent Developments
Table 44. Novartis Company Information, Head Office, Market Area, and Industry Position
Table 45. Novartis CAR-T Cell Therapy Models, Specifications, and Application
Table 46. Novartis CAR-T Cell Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Novartis Company Profile and Main Business
Table 48. Novartis Recent Developments
Table 49. Autolus Company Information, Head Office, Market Area, and Industry Position
Table 50. Autolus CAR-T Cell Therapy Models, Specifications, and Application
Table 51. Autolus CAR-T Cell Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Autolus Company Profile and Main Business
Table 53. Autolus Recent Developments
Table 54. Janssen Company Information, Head Office, Market Area, and Industry Position
Table 55. Janssen CAR-T Cell Therapy Models, Specifications, and Application
Table 56. Janssen CAR-T Cell Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Janssen Company Profile and Main Business
Table 58. Janssen Recent Developments
Table 59. JW Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 60. JW Therapeutics CAR-T Cell Therapy Models, Specifications, and Application
Table 61. JW Therapeutics CAR-T Cell Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. JW Therapeutics Company Profile and Main Business
Table 63. JW Therapeutics Recent Developments
Table 64. Beijing Immunochina Medical Science & Technology Company Information, Head Office, Market Area, and Industry Position
Table 65. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Models, Specifications, and Application
Table 66. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Beijing Immunochina Medical Science & Technology Company Profile and Main Business
Table 68. Beijing Immunochina Medical Science & Technology Recent Developments
Table 69. Bioray Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 70. Bioray Laboratories CAR-T Cell Therapy Models, Specifications, and Application
Table 71. Bioray Laboratories CAR-T Cell Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Bioray Laboratories Company Profile and Main Business
Table 73. Bioray Laboratories Recent Developments
List of Figures
Figure 1. CAR-T Cell Therapy Picture
Figure 2. Global CAR-T Cell Therapy Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global CAR-T Cell Therapy Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global CAR-T Cell Therapy Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China CAR-T Cell Therapy Consumption Value, (US$ million) & (2018-2029)
Figure 6. China CAR-T Cell Therapy Sales Quantity (K Units) & (2018-2029)
Figure 7. China CAR-T Cell Therapy Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China CAR-T Cell Therapy Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China CAR-T Cell Therapy Market Share of Global, 2018-2029
Figure 10. Global CAR-T Cell Therapy Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China CAR-T Cell Therapy Key Participants, Market Share, 2022
Figure 12. Global CAR-T Cell Therapy Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global CAR-T Cell Therapy Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global CAR-T Cell Therapy Production Market Share & Forecast by Region, 2018-2029
Figure 15. CAR-T Cell Therapy Industry Chain
Figure 16. CAR-T Cell Therapy Procurement Model
Figure 17. CAR-T Cell Therapy Sales Model
Figure 18. CAR-T Cell Therapy Sales Channels, Direct Sales, and Distribution
Figure 19. CD19
Figure 20. BCMA
Figure 21. CD19/CD22
Figure 22. Other
Figure 23. By Type, Global CAR-T Cell Therapy Consumption Value, 2018-2029, US$ Million
Figure 24. By Type, Global CAR-T Cell Therapy Consumption Value Market Share, 2018-2029
Figure 25. By Type, Global CAR-T Cell Therapy Sales Quantity, 2018-2029, (K Units)
Figure 26. By Type, Global CAR-T Cell Therapy Sales Quantity Market Share, 2018-2029
Figure 27. By Type, Global CAR-T Cell Therapy Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 28. Non-hodgkin Lymphoma
Figure 29. Multiple Myeloma
Figure 30. Acute Lymphoblastic Leukemia
Figure 31. Other
Figure 32. By Application, Global CAR-T Cell Therapy Consumption Value, 2018-2029, US$ Million
Figure 33. By Application, Global CAR-T Cell Therapy Consumption Value Market Share, 2018-2029
Figure 34. By Application, Global CAR-T Cell Therapy Sales Quantity, 2018-2029, (K Units)
Figure 35. By Application, Global CAR-T Cell Therapy Sales Quantity Market Share, 2018-2029
Figure 36. By Application, Global CAR-T Cell Therapy Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 37. By Region, Global CAR-T Cell Therapy Consumption Value Market Share, 2018-2029
Figure 38. By Region, Global CAR-T Cell Therapy Sales Quantity Market Share, 2018-2029
Figure 39. North America CAR-T Cell Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country, North America CAR-T Cell Therapy Consumption Value Market Share, 2022
Figure 41. Europe CAR-T Cell Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, Europe CAR-T Cell Therapy Consumption Value Market Share, 2022
Figure 43. Asia Pacific CAR-T Cell Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. By Country/Region, Asia Pacific CAR-T Cell Therapy Consumption Value Market Share, 2022
Figure 45. South America CAR-T Cell Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, South America CAR-T Cell Therapy Consumption Value Market Share, 2022
Figure 47. Middle East & Africa CAR-T Cell Therapy Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 48. U.S. CAR-T Cell Therapy Sales Quantity, 2018-2029, (K Units)
Figure 49. By Type, U.S. CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Application, U.S. CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
Figure 51. Europe CAR-T Cell Therapy Sales Quantity, 2018-2029, (K Units)
Figure 52. By Type, Europe CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Application, Europe CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
Figure 54. China CAR-T Cell Therapy Sales Quantity, 2018-2029, (K Units)
Figure 55. By Type, China CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Application, China CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
Figure 57. Japan CAR-T Cell Therapy Sales Quantity, 2018-2029, (K Units)
Figure 58. By Type, Japan CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Application, Japan CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
Figure 60. South Korea CAR-T Cell Therapy Sales Quantity, 2018-2029, (K Units)
Figure 61. By Type, South Korea CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Application, South Korea CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
Figure 63. Southeast Asia CAR-T Cell Therapy Sales Quantity, 2018-2029, (K Units)
Figure 64. By Type, Southeast Asia CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Application, Southeast Asia CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
Figure 66. India CAR-T Cell Therapy Sales Quantity, 2018-2029, (K Units)
Figure 67. By Type, India CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Application, India CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
Figure 69. Middle East & Africa CAR-T Cell Therapy Sales Quantity, 2018-2029, (K Units)
Figure 70. By Type, Middle East & Africa CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
Figure 71. By Application, Middle East & Africa CAR-T Cell Therapy Sales Quantity Market Share, 2022 VS 2029
Figure 72. Research Methodology
Figure 73. Breakdown of Primary Interviews
Figure 74. Bottom-up and Top-down Approaches
Figure 75. Top-down Approaches
Table 1. CAR-T Cell Therapy Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. CAR-T Cell Therapy Market Restraints
Table 3. CAR-T Cell Therapy Market Trends
Table 4. CAR-T Cell Therapy Industry Policy
Table 5. Global CAR-T Cell Therapy Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global CAR-T Cell Therapy Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global CAR-T Cell Therapy Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global CAR-T Cell Therapy Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global CAR-T Cell Therapy Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global CAR-T Cell Therapy Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global CAR-T Cell Therapy Mergers & Acquisitions, Expansion Plans
Table 12. Global CAR-T Cell Therapy Manufacturers Product Type
Table 13. Head Office and CAR-T Cell Therapy Production Site of Key Manufacturer
Table 14. CAR-T Cell Therapy Capacity of Major Manufacturers and Future Plan
Table 15. China CAR-T Cell Therapy Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China CAR-T Cell Therapy Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China CAR-T Cell Therapy Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global CAR-T Cell Therapy Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global CAR-T Cell Therapy Production by Region, 2018-2023, (K Units)
Table 20. Global CAR-T Cell Therapy Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of CAR-T Cell Therapy Upstream (Raw Materials)
Table 22. Global CAR-T Cell Therapy Typical Customers
Table 23. CAR-T Cell Therapy Typical Distributors
Table 24. By Type, Global CAR-T Cell Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global CAR-T Cell Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global CAR-T Cell Therapy Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global CAR-T Cell Therapy Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global CAR-T Cell Therapy Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global CAR-T Cell Therapy Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global CAR-T Cell Therapy Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global CAR-T Cell Therapy Consumption Value Market Share, 2018-2029
Table 32. By Country, Global CAR-T Cell Therapy Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global CAR-T Cell Therapy Sales Quantity Market Share, 2018-2029
Table 34. Bristol Myers Squibb Company Information, Head Office, Market Area, and Industry Position
Table 35. Bristol Myers Squibb CAR-T Cell Therapy Models, Specifications, and Application
Table 36. Bristol Myers Squibb CAR-T Cell Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Bristol Myers Squibb Company Profile and Main Business
Table 38. Bristol Myers Squibb Recent Developments
Table 39. Gilead Sciences Company Information, Head Office, Market Area, and Industry Position
Table 40. Gilead Sciences CAR-T Cell Therapy Models, Specifications, and Application
Table 41. Gilead Sciences CAR-T Cell Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Gilead Sciences Company Profile and Main Business
Table 43. Gilead Sciences Recent Developments
Table 44. Novartis Company Information, Head Office, Market Area, and Industry Position
Table 45. Novartis CAR-T Cell Therapy Models, Specifications, and Application
Table 46. Novartis CAR-T Cell Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Novartis Company Profile and Main Business
Table 48. Novartis Recent Developments
Table 49. Autolus Company Information, Head Office, Market Area, and Industry Position
Table 50. Autolus CAR-T Cell Therapy Models, Specifications, and Application
Table 51. Autolus CAR-T Cell Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Autolus Company Profile and Main Business
Table 53. Autolus Recent Developments
Table 54. Janssen Company Information, Head Office, Market Area, and Industry Position
Table 55. Janssen CAR-T Cell Therapy Models, Specifications, and Application
Table 56. Janssen CAR-T Cell Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Janssen Company Profile and Main Business
Table 58. Janssen Recent Developments
Table 59. JW Therapeutics Company Information, Head Office, Market Area, and Industry Position
Table 60. JW Therapeutics CAR-T Cell Therapy Models, Specifications, and Application
Table 61. JW Therapeutics CAR-T Cell Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. JW Therapeutics Company Profile and Main Business
Table 63. JW Therapeutics Recent Developments
Table 64. Beijing Immunochina Medical Science & Technology Company Information, Head Office, Market Area, and Industry Position
Table 65. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Models, Specifications, and Application
Table 66. Beijing Immunochina Medical Science & Technology CAR-T Cell Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Beijing Immunochina Medical Science & Technology Company Profile and Main Business
Table 68. Beijing Immunochina Medical Science & Technology Recent Developments
Table 69. Bioray Laboratories Company Information, Head Office, Market Area, and Industry Position
Table 70. Bioray Laboratories CAR-T Cell Therapy Models, Specifications, and Application
Table 71. Bioray Laboratories CAR-T Cell Therapy Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Bioray Laboratories Company Profile and Main Business
Table 73. Bioray Laboratories Recent Developments
List of Figures
Figure 1. CAR-T Cell Therapy Picture
Figure 2. Global CAR-T Cell Therapy Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global CAR-T Cell Therapy Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global CAR-T Cell Therapy Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China CAR-T Cell Therapy Consumption Value, (US$ million) & (2018-2029)
Figure 6. China CAR-T Cell Therapy Sales Quantity (K Units) & (2018-2029)
Figure 7. China CAR-T Cell Therapy Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China CAR-T Cell Therapy Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China CAR-T Cell Therapy Market Share of Global, 2018-2029
Figure 10. Global CAR-T Cell Therapy Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China CAR-T Cell Therapy Key Participants, Market Share, 2022
Figure 12. Global CAR-T Cell Therapy Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global CAR-T Cell Therapy Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global CAR-T Cell Therapy Production Market Share & Forecast by Region, 2018-2029
Figure 15. CAR-T Cell Therapy Industry Chain
Figure 16. CAR-T Cell Therapy Procurement Model
Figure 17. CAR-T Cell Therapy Sales Model
Figure 18. CAR
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|